Auf dieser Seite
VANI Vivani Medical, Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$1,23
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,9252-Wochen-Tief
$1,9252-Wochen-Hoch
Marktkapitalisierung (MRQ)
$110M
P/E
-3.2
EPS
$-0.43
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$1–$2
Analystenbewertung
BUY
Kursziel
$4
P/E
-3.2
ROE
-257.8%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VANI Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.23
Marktkapitalisierung (MRQ)
$110M
P/E
-3.2
EPS
$-0.43
Umsatz
$0
ROE
-257.8%
52W-Spanne
$1–$2
VANI Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 19. August 2022 | 1-for-3 | Umgekehrt |
| 6. Januar 2020 | 1-for-8 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02016-12-31 → 2025-12-31
EPS$-0.432023-12-31 → 2025-12-31
Freier Cashflow$-25M2016-12-31 → 2025-12-31
Nettogewinnmarge·2016-12-31 → 2018-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VANI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -3.25-Jahres-Durchschnitt ≈-2.5 | ≈-2.5 | · | · | |
| K/B (MRQ) | 5.85-Jahres-Durchschnitt ≈2.7 | ≈2.7 | 4.0 | Überbewertet | |
| Kurs / FCF (TTM) | -4.15-Jahres-Durchschnitt ≈-2.3 | ≈-2.3 | · | · | |
| Kurs / Cashflow (TTM) | -4.35-Jahres-Durchschnitt ≈-2.4 | ≈-2.4 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 6.65-Jahres-Durchschnitt ≈2.2 | ≈2.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VANI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -65.7%5-Jahres-Durchschnitt ≈-55.4% | ≈-55.4% | -57.2% | Schwach | |
| ROE | -257.8%5-Jahres-Durchschnitt ≈-131.7% | ≈-131.7% | -41.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VANI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.25-Jahres-Durchschnitt ≈4.3 | ≈4.3 | 4.5 | Unterdurchschnittlich | |
| Quick Ratio | 2.55-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 4.1 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | VANI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.0 | · | 0.1 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
2.1%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 18, 2026 | $-0.07 | $-0.09 | 17.6% |
| 31. März 2026 | Mai 18, 2026 | $-0.08 | $-0.08 | 2.0% |
| 31. Dezember 2025 | $-0.09 | $-0.10 | 11.8% | |
| 30. September 2025 | $-0.11 | $-0.11 | 2.0% | |
| 30. Juni 2025 | $-0.12 | $-0.10 | -17.6% | |
| 31. März 2025 | $-0.11 | $-0.11 | -2.7% | |
| 31. Dezember 2024 | $-0.11 | $-0.11 | 2.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | · | · | $3M | $7M | $8M | $4M | $9M | $3M | |
| Cost of Revenue | · | · | · | · | $130.0K | $500.0K | $2M | $5M | $5M | $10M | $5M | $4M | |
| Gross Profit | · | · | · | · | $130.0K | $500.0K | $1M | $2M | $3M | $-6M | $4M | $-160.0K | |
| R&D Expense | $18M | $16M | $17M | $14M | $11M | $5M | $13M | $10M | $8M | $5M | $3M | $5M | |
| SG&A Expense | $9M | $9M | $10M | $7M | $2M | $6M | $9M | $11M | $11M | $10M | $8M | $7M | |
| Operating Expenses | $28M | $25M | $27M | $21M | $13M | $15M | $35M | $37M | $31M | $27M | $24M | $21M | |
| Operating Income | $-28M | $-25M | $-27M | $-21M | $-13M | $-15M | $-34M | $-35M | $-29M | $-33M | $-20M | $-21M | |
| Interest Income | · | · | · | $475.0K | $550.0K | $16.0K | $362.0K | $86.0K | $93.0K | $31.0K | $2.0K | $9.0K | |
| Other Non-op | $947.0K | $1M | $1M | · | · | · | · | · | · | · | $27.0K | $12.0K | |
| Pretax Income | $-27M | $-23M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | · | $2.0K | · | · | · | · | $0 | $0 | · | · | · | · | |
| Net Income | $-27M | $-23M | $-26M | $-14M | $-13M | $-15M | $-34M | $-35M | $-29M | $-33M | $-20M | $-35M | |
| EPS (Basic) | $-0.43 | $-0.43 | $-0.50 | · | · | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.43 | $-0.43 | $-0.50 | · | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 62,389,000 | 54,981,000 | 50,853 | · | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 62,389,000 | 54,981,000 | 50,853 | · | · | · | · | · | · | · | · | · | |
| EBITDA | $-27M | $-24M | $-27M | $-21M | · | · | · | $-35M | $-28M | $-33M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $18M | $21M | $45M | $2M | $2M | $11M | $4M | $8M | $11M | $16M | $619.0K | |
| Receivables | · | · | · | · | · | · | $455.0K | $504.0K | $2M | $274.0K | $2M | $708.0K | |
| Inventory | · | · | · | · | · | · | $1M | $3M | $3M | $3M | $8M | $6M | |
| Prepaid Expense | $1M | $2M | $2M | $2M | $291.0K | $1M | $299.0K | $1M | $795.0K | $717.0K | $1M | $927.0K | |
| Current Assets | $18M | $20M | $23M | $48M | $2M | $4M | $13M | $10M | $13M | $15M | $27M | $42M | |
| PP&E (Net) | $3M | $2M | $2M | $1M | $1M | $174.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $6M | $4M | $4M | $4M | $3M | $653.0K | $5M | $4M | $4M | $4M | $6M | $5M | |
| Accum. Depreciation | $3M | $3M | $2M | $2M | $2M | $479.0K | $4M | $3M | $3M | $2M | $5M | $4M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Total Assets | $39M | $42M | $46M | $51M | $5M | $4M | $17M | $11M | $14M | $17M | $28M | $43M | |
| Accounts Payable | $1M | $817.0K | $542.0K | $1M | $281.0K | $486.0K | $1M | $1M | $752.0K | $1M | $710.0K | $513.0K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $895.0K | $1M | $2M | $3M | $2M | $2M | $2M | $1M | |
| Current Liabilities | $7M | $6M | $6M | $7M | $2M | $5M | $7M | $8M | $7M | $6M | $8M | $8M | |
| Capital Leases | $17M | $18M | $19M | · | $902.0K | · | $2M | · | · | · | · | · | |
| Total Liabilities | $24M | $24M | $25M | $7M | $3M | $5M | $9M | $8M | · | · | · | · | |
| Common Stock | $8.0K | $6.0K | $5.0K | $5.0K | $55M | $270M | $264M | $229M | $202M | $187M | $166M | $163M | |
| Paid-in Capital | $164M | $139M | $119M | $117M | $7M | $49M | $49M | $44M | $41M | $31M | $27M | $25M | |
| Retained Earnings | $-149M | $-122M | $-98M | $-73M | $-59M | $-320M | $-305M | $-269M | $-234M | $-206M | $-173M | $-153M | |
| AOCI | $30.0K | $48.0K | $140.0K | $35.0K | · | $-448.0K | $-562.0K | $-575.0K | $-572.0K | $-608.0K | $-581.0K | $-474.0K | |
| Stockholders' Equity | $16M | $18M | $21M | $44M | $2M | $2M | $7M | $3M | $8M | $11M | $20M | $35M | |
| Liabilities + Equity | $39M | $42M | $46M | $51M | $5M | $4M | $17M | $11M | $14M | $17M | $28M | $43M | |
| Shares Outstanding | 76,428,000 | 59,235,000 | 51,031,000 | 50,736,000 | 36,803 | 32,197 | 15,643 | 9,542,000 | 7,204 | 42,701,000 | 35,942,000 | 35,241,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $424.0K | $400.0K | $357.0K | $381.0K | $345.0K | $164.0K | $397.0K | $435.0K | $457.0K | $432.0K | $335.0K | $279.0K | |
| Stock-based Comp | $1M | $2M | $2M | $1M | $2M | $421.0K | $3M | $4M | $4M | $3M | $3M | $1M | |
| Restructuring | · | · | · | · | · | $2M | $3M | $555.0K | · | · | · | · | |
| Other Non-cash | $381.0K | $690.0K | $-268.0K | $-7M | · | · | · | $1M | $328.0K | $4M | · | · | |
| Operating Cash Flow | $-24M | $-21M | $-24M | $-19M | $-11M | $-17M | $-28M | $-30M | $-24M | $-25M | $-21M | $-17M | |
| CapEx | $1M | $556.0K | $887.0K | $338.0K | $572.0K | $330.0K | $493.0K | $163.0K | $265.0K | $490.0K | $762.0K | $560.0K | |
| Investing Cash Flow | $-1M | $-556.0K | $-887.0K | $-338.0K | $-572.0K | $68.0K | $-493.0K | $-163.0K | $-265.0K | $-490.0K | $18M | $-26M | |
| Stock Issued | · | · | · | · | · | · | · | $26M | $21M | $19M | · | $43M | |
| Net Stock Activity | · | · | · | · | · | · | · | $26M | · | · | · | · | |
| Financing Cash Flow | $23M | $19M | $133.0K | $63M | $12M | $9M | $35M | $27M | $21M | $20M | $3M | $44M | |
| Net Change in Cash | $-2M | $-2M | $-24M | $44M | $97.0K | $-8M | $7M | $-3M | $-3M | $-5M | $-380.0K | $557.0K | |
| Taxes Paid | · | $2.0K | $1.0K | · | $1.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-25M | $-21M | $-25M | $-19M | · | · | · | $-30M | $-24M | $-26M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 29.1% | 35.8% | -152.3% | · | · | |
| Operating Margin | · | · | · | · | · | · | · | -510.1% | -359.2% | -830.2% | · | · | |
| Net Margin | · | · | · | · | · | · | · | -508.9% | -358.1% | -829.5% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | -503.8% | -353.5% | -819.4% | · | · | |
| ROA | -65.7% | -53.8% | -52.9% | -49.1% | · | · | · | -278.8% | -182.2% | -147.3% | · | · | |
| ROE | -257.8% | -130.7% | -109.2% | -29.0% | · | · | · | -1006.1% | -273.5% | -209.0% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 3.4 | 4.0 | 7.0 | · | · | · | 1.3 | 2.0 | 2.7 | · | · | |
| Quick Ratio | 2.5 | 3.1 | 3.6 | · | · | · | · | 0.7 | 0.4 | 0.1 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | 0.5 | 0.5 | 0.2 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 1.6 | 1.7 | 1.7 | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 5.9 | 7.6 | 4.5 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.21 | $0.30 | $406.83 | $0.87 | · | · | · | $0.04 | $0.14 | $261.07 | · | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.39 | $-378.06 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.21 | $0.31 | $404.73 | · | · | · | · | $0.06 | $0.01 | $12.62 | · | · | |
| EPS (TTM) | $-0.43 | $-0.43 | $-0.50 | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $7M | $8M | $4M | $9M | $3M | |
| Net Income TTM | $-27M | $-23M | $-26M | $-14M | $-13M | $-15M | $-34M | $-35M | $-29M | $-33M | $-20M | $-35M | |
| Market Cap | $94M | $69M | $52.1K | $43M | · | · | · | $1.62B | $2.64B | $2M | · | · | |
| P/E | -2.9 | -2.7 | -2.0 | · | · | · | · | · | · | · | · | · | |
| P/S | · | · | 0.0 | 12.8 | · | · | · | 235.2 | 331.7 | 0.5 | · | · | |
| P/B | 6.0 | 3.9 | 0.0 | 1.0 | · | · | · | 526.3 | 335.2 | 0.2 | · | · | |
| P / Tangible Book | 6.0 | 3.9 | 0.0 | 1.0 | 0.1 | 66.8 | · | · | · | · | · | · | |
| P / Cash Flow | -3.9 | -3.3 | -0.0 | -2.3 | · | · | · | -54.5 | -110.3 | -0.1 | · | · | |
| P / FCF | -3.7 | -3.2 | -0.0 | -2.3 | · | · | · | -54.2 | -109.1 | -0.1 | · | · | |
| Earnings Yield | -35.0% | -37.1% | -49.0% | · | · | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 | $0 | · | $0 | · | · | · | · | · | · | · | · | |
| R&D Expense | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $2M | |
| Operating Expenses | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $5M | |
| Operating Income | $-7M | $-7M | $-7M | $-7M | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-6M | $-7M | $-7M | $-7M | $-8M | $-5M | |
| Other Non-op | $504.0K | $-167.0K | $2M | $-195.0K | $-318.0K | $-255.0K | $2M | $-262.0K | $-311.0K | $-188.0K | · | · | · | · | · | · | |
| Net Income | $-6M | $-7M | $-7M | $-7M | $-7M | $-6M | $-6M | $-6M | $-5M | $-6M | $-6M | $-7M | $-7M | $-6M | $-7M | $1M | |
| EPS (Basic) | $-0.07 | $-0.08 | $-0.09 | $-0.11 | $-0.12 | $-0.11 | $-0.10 | $-0.11 | $-0.10 | $-0.12 | $-0.36 | $-0.13 | $-0.13 | $0.12 | · | $0.04 | |
| EPS (Diluted) | $-0.07 | $-0.08 | $-0.09 | $-0.11 | $-0.12 | $-0.11 | $-0.10 | $-0.11 | $-0.10 | $-0.12 | $-0.11 | $-0.13 | $-0.13 | · | · | $0.04 | |
| Shares (Basic) | 87,090,000 | 81,269,000 | · | 59,711,000 | 59,244,000 | 59,236,000 | · | 55,247,000 | 55,021,000 | 52,202,000 | · | 50,837,000 | 50,795,000 | 50,755,000 | · | 37,965 | |
| Shares (Diluted) | 87,090,000 | 81,269,000 | · | 59,711,000 | 59,244,000 | 59,236,000 | · | 55,247,000 | 55,021,000 | 52,202,000 | · | 50,837,000 | 50,795,000 | 50,755 | · | 38,477 | |
| EBITDA | $-7M | $-7M | · | $-7M | $-7M | $-6M | · | $-6M | $-6M | $-6M | · | $-7M | $-7M | $-6M | · | $-5M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $20M | $16M | $3M | $7M | $13M | $18M | $20M | $25M | $30M | $21M | $25M | $32M | $38M | $45M | $52M | |
| Receivables | · | $12.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $1M | $1M | $883.0K | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $6M | $4M | $3M | $2M | $3M | |
| Current Assets | $22M | $22M | $18M | $4M | $9M | $15M | $20M | $21M | $26M | $32M | $23M | $31M | $36M | $41M | $48M | $54M | |
| PP&E (Net) | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $4M | $4M | $6M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-current Assets | $892.0K | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | $1M | · | |
| Total Assets | $42M | $42M | $39M | $25M | $29M | $35M | $42M | $43M | $48M | $54M | $46M | $53M | $60M | $45M | $51M | $57M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $2M | $1M | $817.0K | $815.0K | $645.0K | $570.0K | $542.0K | $2M | $2M | $746.0K | $1M | $2M | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $6M | $7M | $6M | |
| Capital Leases | $16M | $16M | $17M | $17M | $17M | $18M | $18M | $18M | $19M | $19M | $19M | $20M | $20M | $349.0K | · | $42.0K | |
| Total Liabilities | $23M | $23M | $24M | $24M | $24M | $24M | $24M | $25M | $24M | $25M | $25M | $27M | $27M | $6M | $7M | $6M | |
| Common Stock | $9.0K | $8.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $109M | $5.0K | $109M | |
| Paid-in Capital | $181M | $174M | $164M | $143M | $140M | $140M | $139M | $134M | $134M | $133M | $119M | $119M | $118M | $8M | $117M | $8M | |
| Retained Earnings | $-162M | $-155M | $-149M | $-142M | $-135M | $-128M | $-122M | $-116M | $-110M | $-104M | $-98M | $-92M | $-86M | $-79M | $-73M | $-66M | |
| AOCI | $32.0K | $32.0K | $30.0K | $141.0K | $81.0K | $42.0K | $48.0K | $92.0K | $63.0K | $88.0K | $140.0K | $46.0K | $65.0K | $44.0K | $35.0K | $-26.0K | |
| Stockholders' Equity | $19M | $19M | $16M | $1M | $5M | $12M | $18M | $18M | $24M | $29M | $21M | $26M | $32M | $38M | $44M | $51M | |
| Liabilities + Equity | $42M | $42M | $39M | $25M | $29M | $35M | $42M | $43M | $48M | $54M | $46M | $53M | $60M | $45M | $51M | $57M | |
| Shares Outstanding | 89,410,000 | 84,648,000 | 76,428,000 | 61,511,000 | 59,244,000 | 59,244,000 | 59,235,000 | 55,266,000 | 55,197,000 | 54,978 | 51,031,000 | 51,025 | 50,799 | 50,789 | 50,736 | 50,736 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $130.0K | $115.0K | $105.0K | $102.0K | $102.0K | $89.0K | $112.0K | $100.0K | $99.0K | $98.0K | $71.0K | $80.0K | $108.0K | $110.0K | $240.0K | |
| Stock-based Comp | $313.0K | $312.0K | $467.0K | $276.0K | $391.0K | $350.0K | $402.0K | $472.0K | $383.0K | $353.0K | $460.0K | $511.0K | $524.0K | $369.0K | $171.0K | $1M | |
| Other Non-cash | · | $142.0K | · | · | · | $687.0K | · | · | · | $1M | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-6M | $-6M | $-7M | $-6M | $-6M | $-5M | $-6M | $-6M | $-5M | $-5M | $-3M | $-8M | $-6M | $-7M | $-5M | $-8M | |
| CapEx | $99.0K | $3.0K | $274.0K | $823.0K | $71.0K | $5.0K | $296.0K | $41.0K | $37.0K | $182.0K | $743.0K | $63.0K | $44.0K | $37.0K | $89.0K | $231.0K | |
| Investing Cash Flow | $-99.0K | $-3.0K | $-274.0K | $-823.0K | $-71.0K | $-5.0K | $-296.0K | $-41.0K | $-37.0K | $-182.0K | $-743.0K | $-63.0K | $-44.0K | $-37.0K | $-41.0K | $8M | |
| Financing Cash Flow | $6M | $10M | $21M | $3M | $-95.0K | $-170.0K | $5M | $427.0K | $109.0K | $14M | $23.0K | $103.0K | · | · | $0 | $55M | |
| Net Change in Cash | $-301.0K | $4M | $14M | $-4M | $-6M | $-5M | $-1M | $-5M | $-5M | $9M | $-4M | $-8M | $-6M | $-7M | $-5M | $63M | |
| Taxes Paid | · | · | · | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | · | · | $0 | $1.0K | · | · | |
| Free Cash Flow | · | $-6M | · | · | · | $-5M | · | · | · | $-5M | · | · | · | $-7M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.1% | -17.4% | · | -19.2% | -18.5% | -14.1% | · | -12.6% | -9.9% | -12.3% | · | -12.3% | -10.4% | -11.2% | · | 2.2% | |
| ROE | -53.4% | -44.2% | · | -66.5% | -49.7% | -31.2% | · | -27.1% | -19.1% | -18.0% | · | -17.5% | -13.7% | -12.1% | · | 2.4% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.2 | · | 0.6 | 1.3 | 2.4 | · | 3.4 | 4.6 | 5.1 | · | 4.1 | 5.1 | 6.9 | · | 9.7 | |
| Quick Ratio | 3.0 | 2.9 | · | 0.4 | 1.0 | 2.1 | · | 3.1 | 4.3 | 4.8 | · | 3.3 | 4.6 | 6.5 | · | 9.2 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.21 | $0.23 | · | $0.02 | $0.08 | $0.20 | · | $0.33 | $0.43 | $522.21 | · | $513.61 | $637.69 | $755.44 | · | $1012.30 | |
| Revenue / Share | · | · | · | · | · | $0.00 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.09 | · | · | · | · | · | · | · | $-137.25 | · | · | |
| Cash / Share | $0.22 | $0.23 | · | $0.04 | $0.11 | $0.22 | · | $0.36 | $0.45 | $539.27 | · | $486.45 | $639.50 | $749.63 | · | $1018.68 | |
| EPS (TTM) | $-0.35 | $-0.40 | · | $-0.44 | $-0.44 | $-0.42 | · | $-0.44 | $-0.46 | $-0.49 | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $-26M | $-27M | · | $-26M | $-26M | $-24M | · | $-23M | $-24M | $-25M | · | $-27M | $-19M | $-16M | · | $-10M | |
| Market Cap | $111M | $85M | · | $87M | $76M | $62M | · | $65M | $70M | $101.7K | · | $52.0K | $61.5K | $50.8K | · | $115.7K | |
| P/E | -3.5 | -2.5 | · | -3.2 | -2.9 | -2.5 | · | -2.7 | -2.7 | -3.8 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | 20.6 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| P/B | 5.8 | 4.4 | · | 66.3 | 15.6 | 5.4 | · | 3.5 | 2.9 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| P / Tangible Book | 5.8 | 4.4 | · | 66.3 | 15.6 | 5.4 | · | 3.5 | 2.9 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| P / Cash Flow | · | -13.7 | · | · | · | -12.0 | · | · | · | -0.0 | · | · | · | -0.0 | · | · | |
| Earnings Yield | -28.2% | -40.0% | · | -31.2% | -34.1% | -40.0% | · | -37.6% | -36.5% | -26.5% | · | · | · | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $0 | $0 | · | · | · |
| Nettoergebnis | $-27M | $-23M | $-26M | $-14M | $-13M |
| Verwässerte EPS | $-0.43 | $-0.43 | $-0.50 | · | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.7 | 3.4 | 4.0 | 7.0 | · |
| Quick Ratio | 2.5 | 3.1 | 3.6 | · | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-25M | $-21M | $-25M | $-19M | · |
Institutionelle Eigentümer (13F) 37 Einreicher · $8.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
37
Gehaltener Wert
$8.0M
Neue Positionen
6
Geschlossene Positionen
13
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 6 (-8 vs. Vorquartal) | 13 (+9 vs. Vorquartal) | 7 (+1 vs. Vorquartal) | 12 (+3 vs. Vorquartal) | -406K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.192.415 | 1.768.077 | 27,25% | Aktien |
| VANGUARD GROUP INC | $1.909.955 | 1.552.809 | 23,74% | Aktien |
| Tanager Wealth Management LLP | $753.022 | 607.276 | 9,36% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $728.911 | 587.745 | 9,06% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $509.518 | 410.902 | 6,33% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $409.900 | 330.565 | 5,09% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $403.573 | 325.462 | 5,02% | Aktien |
| BlackRock, Inc. | $374.267 | 301.828 | 4,65% | Aktien |
| STATE STREET CORP | $192.157 | 154.965 | 2,39% | Aktien |
| NORTHERN TRUST CORP | $144.965 | 116.907 | 1,80% | Aktien |
| MAI Capital Management | $123.839 | 99.870 | 1,54% | Aktien |
| UBS Group AG | $63.374 | 51.108 | 0,79% | Aktien |
| ARMSTRONG ADVISORY GROUP, INC | $55.800 | 45.000 | 0,69% | Aktien |
| XTX Topco Ltd | $38.810 | 31.298 | 0,48% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $35.149 | 28.346 | 0,44% | Aktien |
| Vanguard Global Advisers, LLC | $20.186 | 16.279 | 0,25% | Aktien |
| StoneX Group Inc. | $18.634 | 14.143 | 0,23% | Aktien |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $15.148 | 12.216 | 0,19% | Aktien |
| Headlands Technologies LLC | $13.976 | 11.271 | 0,17% | Aktien |
| MARSHALL WACE, LLP | $13.839 | 11.161 | 0,17% | Aktien |
| LAZARI CAPITAL MANAGEMENT, INC. | $12.400 | 10.000 | 0,15% | Aktien |
| JPMORGAN CHASE & CO | $4.101 | 3.389 | 0,05% | Aktien |
| Tower Research Capital LLC (TRC) | $3.750 | 3.024 | 0,05% | Aktien |
| Steward Partners Investment Advisory, LLC | $2.480 | 2.000 | 0,03% | Aktien |
| SBI Securities Co., Ltd. | $1.443 | 1.164 | 0,02% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $1.440 | 1.200 | 0,02% | Aktien |
| BARCLAYS PLC | $822 | 663 | 0,01% | Aktien |
| Strategic Wealth Partners, Ltd. | $496 | 400 | 0,01% | Aktien |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $384 | 312 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $272 | 220 | 0,00% | Aktien |
| FMR LLC | $176 | 142 | 0,00% | Aktien |
| NFSG Corp | $128 | 103 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $75 | 60.866 | 0,00% | Aktien |
| HRT FINANCIAL LP | $17 | 13.947 | 0,00% | Aktien |
| MORGAN STANLEY | $12 | 10 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $7 | 6 | 0,00% | Aktien |
| DANSKE BANK A/S | $1 | 1 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Williams Gregg, Gregg G. Williams 2006 Trust, Sam Williams Family Investments LLC, Williams International Co. LLC, Sam B. Williams 1995 Generation Skipping Trust | 19. Mai 2026 | 47,10% | Änderung | Passive Anlage | SEC |
| Gregg Williams, Gregg G. Williams 2006 Trust, Sam Williams Family Investments LLC, Williams International Co. LLC, Sam B. Williams 1995 Generation Skipping Trust ×11 Einreichungen | 2. Mai 2023 | · | Erste Einreichung | Passive Anlage | SEC |
| Joachim Bolck 2) | 25. April 2023 | · | Erste Einreichung | Passive Anlage | SEC |
| Adam Mendelsohn 2) | 1. September 2022 | · | Erste Einreichung | Passive Anlage | SEC |
| Pixium Vision, S.A. | 8. Januar 2021 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 28 Insider · 17 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Adam Mendelsohn | Chief Executive Officer | 28. Juli 2026 A | 3.605.015 | 0 | 0 | $0 |
| Anthony Baldor | Chief Financial Officer | 28. Juli 2026 A | · | 0 | 0 | $0 |
| Brigid Makes | Chief Financial Officer | 12. Mai 2025 A | 15.000 | 0 | 0 | $0 |
| John T Blake | Chief Financial Officer | 19. Februar 2020 M | 1.754 | 0 | 0 | $0 |
| Thomas B Miller | Chief Financial Officer | 19. Januar 2018 A | 78.354 | 0 | 0 | $0 |
| William Patrick Ryan | Chief Operating Officer | 19. Februar 2020 M | 2.261 | 0 | 0 | $0 |
| Lisa Ellen Porter | Chief Medical Officer | 28. Juli 2026 A | · | 0 | 0 | $0 |
| Donald Dwyer | Chief Business Officer | 28. Juli 2026 A | 55.000 | 0 | 0 | $0 |
| Truc Le | Chief Operations Officer | 28. Juli 2026 A | · | 0 | 0 | $0 |
| Jessy Dana Dorn | VP-Clin & Scientific Affairs | 12. Februar 2020 A | 1.458 | 0 | 0 | $0 |
| Edward David Randolph | Vice President Manufacturing | 4. Juni 2019 S | 22 | 0 | 0 | $0 |
| Stephen D Okland | Chief Commercial Officer | 19. Februar 2019 A | 23.641 | 0 | 0 | $0 |
| David Murray Jacques | VP-Research Development | 4. Januar 2018 A | · | 0 | 0 | $0 |
| Robert J. Greenberg | Chairman of Board | 4. Januar 2018 A | 172.911 | 0 | 0 | $0 |
| Gregoire Cosendai | VP Clinical Affairs | 4. Januar 2018 A | 10.395 | 0 | 0 | $0 |
| John Anthony Moses | Commercial VP Americas | 21. Januar 2016 A | · | 0 | 0 | $0 |
| Anne-Marie Juliette Ripley | VP of Regulatory Affairs | 4. Dezember 2015 M | 0 | 0 | 0 | $0 |
| Daniel Bradbury | Direktor | 27. Juli 2026 A | · | 0 | 0 | $0 |
| Gregg Williams | Direktor | 15. Juli 2026 P | 36.912.736 | 18 | 0 | $26.599.995 |
| Alexandra L.P. Larson | Direktor | 24. Juni 2026 A | 2.166 | 0 | 0 | $0 |
| Aaron Mendelsohn | Direktor | 24. Juni 2026 A | 188.170 | 1 | 0 | $24.600 |
| August J Moretti | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Wilford Dean Baker | Direktor | 24. Juni 2025 A | 197.482 | 0 | 0 | $0 |
| Jonathan Will Mcguire | Direktor | 19. Mai 2020 D | 20.469 | 0 | 0 | $0 |
| William J Link PHD | Direktor | 4. Juni 2019 A | 115.186 | 0 | 0 | $0 |
| Matthew J Pfeffer | Direktor | 4. Juni 2019 A | 118.301 | 0 | 0 | $0 |
| Alfred E Mann | Direktor | 1. Juni 2015 A | 33.198 | 0 | 0 | $0 |
| Joachim Eberhard Bolck | 10%-Eigentümer | 3. Januar 2023 P | 2.524.229 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
VANI Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$4.00
+225,2%
2 20,0%
Starker Kauf
7 70,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-09-30Mittelwert-Ziel $3.83 +211,7%
← Unter allen Zielen
Aktueller Preis $1.23
Tief$3.50
Mittelwert$3.83
Hoch$4.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| LNSR | · | -4.1 | 9.2% | · | · | · |
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| MBOT | $134M | -6.9 | · | · | -24.4% | · |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| STEX | $151M | -0.3 | 122.2% | 29068.8% | -703.0% | · |
| GUTS | $337M | -1.2 | -22.5% | · | 3220.3% | · |
| DXR | · | · | · | · | · | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026